This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Amiodarone
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
Amiodarone is a blocker of [[Potassium Channel|voltage gated potassium]] (more exactly KCNH2) and [[Voltage-gated calcium channels|voltage gated calcium channels]] (more exactly CACNA2D2).<ref name="a50">[https://go.drugbank.com/drugs/DB01118 "Amiodarone".] Drugbank. Retrieved 28 May 2019.</ref> | Amiodarone is a blocker of [[Potassium Channel|voltage gated potassium]] (more exactly KCNH2) and [[Voltage-gated calcium channels|voltage gated calcium channels]] (more exactly CACNA2D2).<ref name="a50">[https://go.drugbank.com/drugs/DB01118 "Amiodarone".] Drugbank. Retrieved 28 May 2019.</ref> | ||
| - | [[8e56]] | + | <scene name='10/1017435/Cv/2'>Voltage-dependent L-type calcium channel subunit alpha-1S with Amiodarone</scene> ([[8e56]]). |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 13:56, 18 December 2023
| |||||||||||
References
- ↑ "Amiodarone Hydrochloride". The American Society of Health-System Pharmacists. Archived from the original on 19 September 2016. Retrieved 22 August 2016
- ↑ "Amiodarone". Drugbank. Retrieved 28 May 2019.
